The Arrhythmia Patient in the CCU – Impact of Echocardiography

  • Alan Sugrue
  • Subir Bhatia
  • Vaibhav Vaidya
  • Sam Asirvatham
Chapter

Abstract

Echocardiography is an essential tool in patients with cardiac arrhythmias, particularly in the critical care environment. It plays an important role in the etiological assessment, prognosis, and risk stratification of patients with arrhythmias. In this chapter, we discuss the key role of echocardiography in the arrhythmic patient in the coronary care unit.

Keywords

Atrial fibrillation Syncope Ventricular tachycardia 

References

  1. 1.
    Wren C, Campbell RW, Hunter S. Role of echocardiography in differential diagnosis of broad complex tachycardia. Br Heart J. 1985;54(2):166–72.CrossRefGoogle Scholar
  2. 2.
    Kotecha D, Mohamed M, Shantsila E, Popescu BA, Steeds RP. Is echocardiography valid and reproducible in patients with atrial fibrillation? A systematic review. EP Europace. 2017:eux027.Google Scholar
  3. 3.
    Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–71.CrossRefGoogle Scholar
  4. 4.
    Donal E, Lund LH, Oger E, Reynaud A, Schnell F, Persson H, et al. Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen study. Eur Heart J Cardiovasc Imaging. 2015;17(1):106–13.PubMedGoogle Scholar
  5. 5.
    Punjani S, Wu W-C, Cohen S, Sharma SC, Choudhary G. Echocardiographic indices of diastolic function relate to functional capacity and quality of life in ambulatory men with atrial fibrillation. J Am Soc Echocardiogr. 2011;24(5):533–40.e3.CrossRefGoogle Scholar
  6. 6.
    Turakhia MP, Santangeli P, Winkelmayer WC, Xu X, Ullal AJ, Than CT, et al. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study. J Am Coll Cardiol. 2014;64(7):660–8.CrossRefGoogle Scholar
  7. 7.
    Sleeswijk ME, Van Noord T, Tulleken JE, Ligtenberg JJ, Girbes AR, Zijlstra JG. Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients: a clinical framework. Crit Care. 2007;11(6):233.CrossRefGoogle Scholar
  8. 8.
    Brodsky MA, Allen BJ, Capparelli EV, Luckett CR, Morton R, Henry WL. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. Am J Cardiol. 1989;63(15):1065–8.CrossRefGoogle Scholar
  9. 9.
    Køber L, Torp-Pedersen C, McMurray JJ, Gøtzsche O, Lévy S, Crijns H, et al. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med. 2008;358(25):2678–87.CrossRefGoogle Scholar
  10. 10.
    Chung R, Houghtaling PL, Tchou M, Niebauer MJ, Lindsay BD, Tchou PJ, et al. Left ventricular hypertrophy and antiarrhythmic drugs in atrial fibrillation: impact on mortality. Pacing Clin Electrophysiol. 2014;37(10):1338–48.CrossRefGoogle Scholar
  11. 11.
    Manning WJ, Weintraub RM, Waksmonski CA, Haering JM, Rooney PS, Maslow AD, et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi: a prospective, intraoperative study. Ann Intern Med. 1995;123(11):817–22.CrossRefGoogle Scholar
  12. 12.
    Black IW, Hopkins AP, Lee LC, Walsh WF. Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis. J Am Coll Cardiol. 1991;18(2):398–404.CrossRefGoogle Scholar
  13. 13.
    Goldman ME, Pearce LA, Hart RG, Zabalgoitia M, Asinger RW, Safford R, et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). J Am Soc Echocardiogr. 1999;12(12):1080–7.CrossRefGoogle Scholar
  14. 14.
    Celeste F, Muratori M, Mapelli M, Pepi M. The evolving role and use of echocardiography in the evaluation of cardiac source of embolism. J Cardiovasc Echogr. 2017;27(2):33.CrossRefGoogle Scholar
  15. 15.
    Ayirala S, Kumar S, O'Sullivan DM, Silverman DI. Echocardiographic predictors of left atrial appendage thrombus formation. J Am Soc Echocardiogr. 2011;24(5):499–505.CrossRefGoogle Scholar
  16. 16.
    Ono K, Iwama M, Kawasaki M, Tanaka R, Watanabe T, Onishi N, et al. Motion of left atrial appendage as a determinant of thrombus formation in patients with a low CHADS2 score receiving warfarin for persistent nonvalvular atrial fibrillation. Cardiovasc Ultrasound. 2012;10(1):50.CrossRefGoogle Scholar
  17. 17.
    Breitkreutz R, Walcher F, Ilper H, Seeger FH, Price S, Via G, et al. Focused echocardiography in life support: the subcostal window. Eur J Trauma Emerg Surg. 2009;35(4):347–56.CrossRefGoogle Scholar
  18. 18.
    Tsou P-Y, Kurbedin J, Chen Y-S, Chou EH, Lee M-tG, Lee MC-H, et al. Accuracy of point-of-care focused echocardiography in predicting outcome of resuscitation in cardiac arrest patients: A systematic review and meta-analysis. Resuscitation. 2017;114:92–9.CrossRefGoogle Scholar
  19. 19.
    Labovitz AJ, Noble VE, Bierig M, Goldstein SA, Jones R, Kort S, et al. Focused cardiac ultrasound in the emergent setting: a consensus statement of the American Society of Echocardiography and American College of Emergency Physicians. J Am Soc Echocardiogr. 2010;23(12):1225–30.CrossRefGoogle Scholar
  20. 20.
    Stub D, Bernard S, Duffy SJ, Kaye DM. Post cardiac arrest syndrome. Circulation. 2011;123(13):1428–35.CrossRefGoogle Scholar
  21. 21.
    Cha K-C, Hwang SO, Kim HI, Kim OH, Cha YS, Kim H, et al. Echocardiographic patterns of post-cardiac arrest myocardial dysfunction. Resuscitation. 2018;124:90–5.CrossRefGoogle Scholar
  22. 22.
    Mulpuru SK, Konecny T, Madhavan M, Kapa S, Noseworthy PA, McLeod CJ, et al. Atypical variants of right ventricular outflow arrhythmias. J Cardiovasc Electrophysiol. 2014;25(12):1321–7.PubMedGoogle Scholar
  23. 23.
    Ouyang F, Fotuhi P, Ho SY, Hebe J, Volkmer M, Goya M, et al. Repetitive monomorphic ventricular tachycardia originating from the aortic sinus cusp: electrocardiographic characterization for guiding catheter ablation. J Am Coll Cardiol. 2002;39(3):500–8.CrossRefGoogle Scholar
  24. 24.
    Yamauchi Y, Aonuma K, Takahashi A, Sekiguchi Y, Hachiya H, Yokoyama Y, et al. Electrocardiographic characteristics of repetitive monomorphic right ventricular tachycardia originating near the His-bundle. J Cardiovasc Electrophysiol. 2005;16(10):1041–8.CrossRefGoogle Scholar
  25. 25.
    Chun KR, Satomi K, Kuck KH, Ouyang F, Antz M. Left ventricular outflow tract tachycardia including ventricular tachycardia from the aortic cusps and epicardial ventricular tachycardia. Herz. 2007;32(3):226–32.CrossRefGoogle Scholar
  26. 26.
    Padmanabhan D, Sugrue A, Gaba P, Asirvatham SJ. Outflow tract ventricular arrhythmias. Herzschrittmacherther Elektrophysiol. 2017;28(2):177–86.CrossRefGoogle Scholar
  27. 27.
    Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010;31(7):806–14.CrossRefGoogle Scholar
  28. 28.
    te Riele ASJM, Tandri H, Sanborn DM, Bluemke DA. Noninvasive Multimodality Imaging in ARVD/C. J Am Coll Cardiol Img. 2015;8(5):597–611.CrossRefGoogle Scholar
  29. 29.
    Mehta D, Lubitz SA, Frankel Z, Wisnivesky JP, Einstein AJ, Goldman M, et al. Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest. 2008;133(6):1426–35.CrossRefGoogle Scholar
  30. 30.
    Ayyala US, Nair AP, Padilla ML. Cardiac sarcoidosis. Clin Chest Med. 2008;29(3):493–508, ix.CrossRefGoogle Scholar
  31. 31.
    Sadek MM, Benhayon D, Sureddi R, Chik W, Santangeli P, Supple GE, et al. Idiopathic ventricular arrhythmias originating from the moderator band: electrocardiographic characteristics and treatment by catheter ablation. Heart Rhythm. 2015;12(1):67–75.CrossRefGoogle Scholar
  32. 32.
    Rösner A, Avenarius D, Malm S, Iqbal A, Bijnens B, Schirmer H. Severe regional myocardial dysfunction by stress echocardiography does not predict the presence of transmural scarring in chronic coronary artery disease. Eur Heart J Cardiovasc Imaging. 2015;16(10):1074–81.CrossRefGoogle Scholar
  33. 33.
    Aarsæther E, Rösner A, Straumbotn E, Busund R. Peak longitudinal strain most accurately reflects myocardial segmental viability following acute myocardial infarction—an experimental study in open-chest pigs. Cardiovasc Ultrasound. 2012;10(1):23.CrossRefGoogle Scholar
  34. 34.
    Wolfe CL, Nibley C, Bhandari A, Chatterjee K, Scheinman M. Polymorphous ventricular tachycardia associated with acute myocardial infarction. Circulation. 1991;84(4):1543–51.CrossRefGoogle Scholar
  35. 35.
    Sabia P, Afrookteh A, Touchstone DA, Keller MW, Esquivel L, Kaul S. Value of regional wall motion abnormality in the emergency room diagnosis of acute myocardial infarction. A prospective study using two-dimensional echocardiography. Circulation. 1991;84(3 Suppl):I85–92.PubMedGoogle Scholar
  36. 36.
    Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant. 2013;32(2):141–56.CrossRefGoogle Scholar
  37. 37.
    Rosenbaum AN, Kremers WK, Duval S, Sakaguchi S, John R, Eckman PM. Arrhythmias in patients with cardiac implantable electrical devices after implantation of a left ventricular assist device. ASAIO J. 2016;62(3):274–80.CrossRefGoogle Scholar
  38. 38.
    Vollkron M, Voitl P, Ta J, Wieselthaler G, Schima H. Suction events during left ventricular support and ventricular arrhythmias. J Heart Lung Transplant. 2007;26(8):819–25.CrossRefGoogle Scholar
  39. 39.
    Andersen M, Videbæk R, Boesgaard S, Sander K, Hansen PB, Gustafsson F. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant. 2009;28(7):733–5.CrossRefGoogle Scholar
  40. 40.
    Reesink K, Dekker A, Van der Nagel T, Beghi C, Leonardi F, Botti P, et al. Suction due to left ventricular assist: implications for device control and management. Artif Organs. 2007;31(7):542–9.CrossRefGoogle Scholar
  41. 41.
    Estep JD, Stainback RF, Little SH, Torre G, Zoghbi WA. The role of echocardiography and other imaging modalities in patients with left ventricular assist devices. J Am Coll Cardiol Cardiovasc Imaging. 2010;3(10):1049–64.CrossRefGoogle Scholar
  42. 42.
    Stainback RF, Estep JD, Agler DA, Birks EJ, Bremer M, Hung J, et al. Echocardiography in the management of patients with left ventricular assist devices: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2015;28(8):853–909.CrossRefGoogle Scholar
  43. 43.
    Sacher F, Reichlin T, Zado ES, Field ME, Viles-Gonzalez JF, Peichl P, et al. Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices. Circ Arrhythm Electrophysiol. 2015;8(3):592–7.CrossRefGoogle Scholar
  44. 44.
    Moss JD, Flatley EE, Beaser AD, Shin JH, Nayak HM, Upadhyay GA, et al. Characterization of ventricular tachycardia after left ventricular assist device implantation as destination therapy: a single-center ablation experience. JACC Clin Electrophysiol. 2017;3(12):1412–24.CrossRefGoogle Scholar
  45. 45.
    Pedretti S, Cipriani M, Bonacina E, Vargiu S, Ad VG, Frigerio M, et al. Refractory ventricular tachycardia caused by inflow cannula mechanical injury in a patient with left ventricular assist device: catheter ablation and pathological findings. J Arrhythmia. 2017;33(5):494–6.CrossRefGoogle Scholar
  46. 46.
    Ng PK, Ault MJ, Ellrodt AG, Maldonado L. Peripherally inserted central catheters in general medicine. Mayo Clin Proc. 1997;72(3):225–33.CrossRefGoogle Scholar
  47. 47.
    Vesely TM. Central venous catheter tip position: a continuing controversy. J Vasc Interv Radiol. 2003;14(5):527–34.CrossRefGoogle Scholar
  48. 48.
    Toh N, Nishii N, Nakamura K, Tada T, Oe H, Nagase S, et al. Cardiac dysfunction and prolonged hemodynamic deterioration after implantable cardioverter-defibrillator shock in patients with systolic heart failure. Circ Arrhythm Electrophysiol. 2012;5(5):898–905.CrossRefGoogle Scholar
  49. 49.
    Malawista M. Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med. 1980;93(Part 1):8–16.PubMedGoogle Scholar
  50. 50.
    Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, et al. Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs. N Engl J Med. 2016;375(2):111–21.CrossRefGoogle Scholar
  51. 51.
    Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32–8.CrossRefGoogle Scholar
  52. 52.
    Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2009;53(19):1798–803.CrossRefGoogle Scholar
  53. 53.
    Pedersen ME, Leo M, Kalla M, Malhotra A, Stone M, Wong K, et al. Management of tamponade complicating catheter ablation for atrial fibrillation: early removal of pericardial drains is safe and effective and reduces analgesic requirements and hospital stay compared to conventional delayed removal. JACC Clin Electrophysiol. 2017;3(4):367–73.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Alan Sugrue
    • 1
  • Subir Bhatia
    • 1
  • Vaibhav Vaidya
    • 1
  • Sam Asirvatham
    • 1
    • 2
  1. 1.Division of Heart Rhythm Services, Department of Cardiovascular DiseasesMayo ClinicRochesterUSA
  2. 2.Division of Pediatric Cardiology, Department of Pediatrics and Adolescent MedicineMayo ClinicRochesterUSA

Personalised recommendations